Inhibitors of proline-specific dipeptidyl peptidases: DPP IV inhibitors as a novel approach for the treatment of Type 2 diabetes

about

Predicting the DPP-IV inhibitory activity pIC₅₀ based on their physicochemical properties.

P2860

Q36995316-7252A0B5-2B32-4E4B-B9C8-C2E23686AA91

P2860

Inhibitors of proline-specific dipeptidyl peptidases: DPP IV inhibitors as a novel approach for the treatment of Type 2 diabetes

Item

http://www.wikidata.org/entity/Q58864225

description

im September 2005 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2005

@uk

name

Inhibitors of proline-specific ...... e treatment of Type 2 diabetes

@en

Inhibitors of proline-specific ...... e treatment of Type 2 diabetes

@nl

type

Item

label

Inhibitors of proline-specific ...... e treatment of Type 2 diabetes

@en

Inhibitors of proline-specific ...... e treatment of Type 2 diabetes

@nl

prefLabel

Inhibitors of proline-specific ...... e treatment of Type 2 diabetes

@en

Inhibitors of proline-specific ...... e treatment of Type 2 diabetes

@nl

P1476

Inhibitors of proline-specific ...... e treatment of Type 2 diabetes

@en

P2093

Achiel Haemers

http://www.w3.org/2001/XMLSchema#string

Koen Augustyns

http://www.w3.org/2001/XMLSchema#string

Pieter Van der Veken

http://www.w3.org/2001/XMLSchema#string

P2860

Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase

Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases

Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII

The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism

Identification and characterization of human DPP9, a novel homologue of dipeptidyl peptidase IV

Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors

FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor

Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: a euglycemic-hyperinsulinemic clamp study.

Purification, identification and characterisation of seprase from bovine serum.

Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide.

P304

1387-1407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.15.10.1387

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

type-2 diabetes

Inhibitors of proline-specific dipeptidyl peptidases: DPP IV inhibitors as a novel approach for the treatment of Type 2 diabetes

about

P2860

P2860

Inhibitors of proline-specific dipeptidyl peptidases: DPP IV inhibitors as a novel approach for the treatment of Type 2 diabetes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P921